Biotech · Private company · Durham, NC, US
Lamassu Bio Inc
Track this companyFree. Adds Lamassu Bio Inc to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- SA53-OS (phase 1)Phase 2 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- SA53-OS (phase 2)Phase 2 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- Safety and Preliminary Efficacy of SA53-OS in Patients With Locally Advanced or Metastatic Solid TumorsPHASE1_PHASE2 · RECRUITING · started Jun 16, 2025ClinicalTrials.gov NCT06578624 · fetched Nov 12, 2026
NIH awards1
- Development of a novel small molecule MDM2 inhibitor for innovative sarcoma treatmentFiscal year 2024 · $723.2KNIH RePORTER 5R44CA281622-02 · fetched Nov 12, 2026